
With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates ...
In this interview with Managed Healthcare Executive, Peter Ehrenkranz, M.D., M.P.H., deputy director, HIV, at the Gates Foundation, discusses twice-a-year lenacapavir for HIV preexposure prophylaxis (PrEP). The FDA approved the preventive medication on …